SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001193125-13-344958
Filing Date
2013-08-23
Accepted
2013-08-23 13:20:30
Documents
10
Period of Report
2013-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q AMENDMENT NO. 1 d584653d10qa.htm 10-Q/A 667324
2 EX-31.1 d584653dex311.htm EX-31.1 6666
3 EX-31.2 d584653dex312.htm EX-31.2 6679
4 EX-32.1 d584653dex321.htm EX-32.1 4570
  Complete submission text file 0001193125-13-344958.txt   7589604

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT celphap-20130331.xml EX-101.INS 609000
6 XBRL TAXONOMY EXTENSION SCHEMA celphap-20130331.xsd EX-101.SCH 41471
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE celphap-20130331_cal.xml EX-101.CAL 68639
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE celphap-20130331_def.xml EX-101.DEF 151738
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE celphap-20130331_lab.xml EX-101.LAB 314360
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE celphap-20130331_pre.xml EX-101.PRE 233833
Mailing Address 303B COLLEGE ROAD EAST PRINCETON NJ 08540
Business Address 303B COLLEGE ROAD EAST PRINCETON NJ 08540 (609) 243-0123
Celator Pharmaceuticals Inc (Filer) CIK: 0001327467 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 000-54852 | Film No.: 131057271
SIC: 2834 Pharmaceutical Preparations